Predictors of circulating INTERLEUKIN-6 levels in head and neck cancer patients
Abstract Background Circulating interleukin-6 (IL-6) improves outcome prediction for second primary cancer (SPC) in head and neck cancer (HNC) patients. This study aimed to identify factors associated with IL-6 serum levels in HNC patients. Methods This study was conducted as part of a phase III che...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BioMed Central
2018-05-01
|
Series: | Cancers of the Head & Neck |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s41199-018-0029-5 |